MedTrace Logo

Exploratory Open Label Study for Development of a Method To Detect Dendritic Cells

NCT05482867 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 46

Last updated 2026-07-08

Study results available
· View outcomes & findings →

Summary

This is a proof-of-concept study designed to confirm that human phagocytic cells can be labeled with the near-infrared dye indocyanine green (ICG) and the presence of the labeled cells 48 hours later in cerebral cortex can be inferred using near infrared spectroscopy (NIRS).

Conditions

  • Probable Alzheimer's Disease

Sponsors & Collaborators

  • MindImmune Therapeutics, Inc.

    lead INDUSTRY

Eligibility

Min Age
21 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-11-28
Primary Completion
2024-08-07
Completion
2024-09-17

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05482867 on ClinicalTrials.gov